Development of a stage-dependent prognostic model to predict psychosis in ultra-high-risk patients seeking treatment for co-morbid psychiatric disorders

Psychological Medicine

Volumn 46, Issue 9, 2016, Pages 1839-1851

  Ising, H K ^a   Ruhrmann, S ^b   Burger, N A F M ^a   Rietdijk, J ^a,c   Dragt, S ^d   Klaassen, R M C ^e   Van Den Berg, D P G ^a   Nieman, D H ^d   Boonstra, N ^f   Linszen, D H ^d   Wunderink, L ^f   Smit, F ^c,g,h   Veling, W ⁱ   Van Der Gaag, M ^a,c  

^a PARNASSIA PSYCHIATRIC INSTITUTE   (Netherlands)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f GGZ Foundation for Mental Health Care Friesland   (Netherlands)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Distress; negative symptoms; prognostic index; psychosis prediction; risk stratification; social functioning; ultra high risk

Indexed keywords

ADOLESCENT; ADULT; COMORBIDITY; CONTROLLED STUDY; FOLLOW UP; HUMAN; MENTAL DISEASE; PATHOPHYSIOLOGY; PROGNOSIS; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RISK; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; COMORBIDITY; FOLLOW-UP STUDIES; HUMANS; MENTAL DISORDERS; MODELS, STATISTICAL; PROGNOSIS; PSYCHOTIC DISORDERS; RISK; YOUNG ADULT;

EID: 84961206798     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291716000325     Document Type: Article

References (58)

1. Addington J, Penn D, Woods SW, Addington D, Perkins DO (2008). Social functioning in individuals at clinical high risk for psychosis. Schizophrenia Research 99, 119-124.
2. Andrews G, Peters L (1998). The psychometric properties of the Composite International Diagnostic Interview. Social Psychiatry and Psychiatric Epidemiology 33, 80-88.
3. APA (1987). Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R. Washington, DC: American Psychiatric Association.
4. Beck A, Steer R, Brown G (1996). Manual for Beck Depression Inventory-II. Psychological Corporation: San Antonio, TX.
5. Birchwood M, Jackson C, Brunet K, Holden J, Barton K (2012). Personal beliefs about illness questionnaire-revised (PBIQ-R): reliability and validation in a first episode sample. British Journal of Clinical Psychology 51, 448-458.
6. Brett C, Heriot-Maitland C, McGuire P, Peters E (2014). Predictors of distress associated with psychotic-like anomalous experiences in clinical and non-clinical populations. British Journal of Clinical Psychology 53, 213-227.
7. Cannon TD, Cadenhead K, Cornblatt B,Woods SW, Addington J,Walker E, Seidman LJ, Perkins D, Tsuang M, McGlashan T, Heinssen R (2008). Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of General Psychiatry 65, 28-37.
8. Cornblatt BA, Carrión RE, Addington J, Seidman L, Walker EF, Cannon TD, Cadenhead KS, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Heinssen R, Lencz T (2012). Risk factors for psychosis: impaired social and role functioning. Schizophrenia Bulletin 38, 1247-1257.
9. Cornblatt BA, Carrión RE, Auther A, McLaughlin D, Olsen RH, John M, Correll CU (2015). Psychosis prevention: a modified clinical high risk perspective from the recognition and prevention (RAP) program. American Journal of Psychiatry 172, 986-994.
10. Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E (2003). The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophrenia Bulletin 29, 633-651.
11. Cornblatt B, Lencz T, Obuchowski M (2002). The schizophrenia prodrome: treatment and high-risk perspectives. Schizophr Research 57, 177-186.
12. DemjahaA,Valmaggia L, StahlD,ByrneM,McGuire P (2012). Disorganization/cognitive and negative symptomdimensions in the at-risk mental state predict subsequent transition to psychosis. Schizophrenia Bulletin 38, 351-359.
13. Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, Barale F, Caverzasi E, McGuire P (2012). Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Archives of General Psychiatry 69, 220-229.
14. Fusar-Poli P, Byrne M, Valmaggia L, Day F, Tabraham P, Johns L, McGuire P (2010). Social dysfunction predicts two years clinical outcome in people at ultra high risk for psychosis. Journal of Psychiatric Research 44, 294-301.
15. Fusar-Poli P, Meneghelli A, Valmaggia L, Allen P, Galvan F, McGuire P, Cocchi A (2009). Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosis. British Journal of Psychiatry 194, 181-182.
16. Goldman HH, Skodol AE, Lave TR (1992). Revising axis V for DSM-IV: a review of measures of social functioning. American Journal of Psychiatry 149, 1148-1156.
17. Guillem F, Pampoulova T, Stip E, Lalonde P, Todorov C (2005). The relationships between symptom dimensions and dysphoria in schizophrenia. Schizophrenia Research 75, 83-96.
18. Hosmer Jr. DW, Lemeshow S, May S (1999). Applied Survival Analysis: Regression Modeling of Time to Event Data. John Wiley & Sons: New York.
19. Huber G (1983). The concept of substrate-close basic symptoms and its significance for the theory and therapy of schizophrenic diseases. Der Nervenarzt 54, 23-32.
20. Ising HK, Veling W, Loewy RL, Rietveld MW, Rietdijk J, Dragt S, Klaassen RMC, Nieman DH, Wunderink L, Linszen DH, van der Gaag M (2012). The validity of the 16-item version of the Prodromal Questionnaire (PQ-16) to screen for ultra high risk of developing psychosis in the general help-seeking population. Schizophrenia Bulletin 38, 1288-1296.
21. Krabbendam L, Myin-Germeys I, Hanssen M, Bijl RV, de Graaf R, Vollebergh W, Bak M, van Os J (2004). Hallucinatory experiences and onset of psychotic disorder: evidence that the risk is mediated by delusion formation. Acta Psychiatrica Scandinavica 110, 264-272.
22. Lencz T, Smith CW, Auther A, Correll CU, Cornblatt B (2004). Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophrenia Research 68, 37-48.
23. Loughin TM (1998). On the bootstrap and monotone likelihood in the cox proportional hazards regression model. Lifetime Data Analysis 4, 393-403.
24. Manschreck TC, Chun J, Merrill AM, Maher BA, Boshes RA, Glatt SJ, Faraone SV, Tsuang MT, Seidman LJ (2015). Impaired motor performance in adolescents at familial high-risk for schizophrenia. Schizophrenia Research 168, 44-49.
25. Mason O, Startup M, Halpin S, Schall U, Conrad A, Carr V (2004). Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'. Schizophrenia Research 71, 227-237.
26. Mattick RP, Clarke JC (1998). Development and validation of measures of social phobia scrutiny fear and social interaction anxiety11Editor's note: this article was written before the development of some contemporary measures of social phobia, such as the Social Phobia and Anxiety Inventory. Behaviour Research and Therapy 36, 455-470.
27. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ (2006). Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Australian and New Zealand Journal of Psychiatry 40, 616-622.
28. McGorry PD, Yung AR, Bechdolf A, Amminger P (2008). Back to the future: predicting and reshaping the course of psychotic disorder. Archives of General Psychiatry 65, 25-27.
29. Michel C, Ruhrmann S, Schimmelmann BG, Klosterkotter J, Schultze-Lutter F (2014). A stratified model for psychosis prediction in clinical practice. Schizophrenia Bulletin 40, 1533-1542.
30. Miller TJ, McGlashan TH, Rosen JL, Somjee L, Markovich PJ, Stein K, Woods SW (2002). Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. American Journal of Psychiatry 159, 863-865.
31. Miller TJ, Zipursky RB, Perkins D, Addington J, Woods SW, Hawkins Ka, Hoffman R, Preda A, Epstein I, Addington D, Lindborg S, Marquez E, Tohen M, Breier A, McGlashan TH (2003). The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. Schizophrenia Research 61, 19-30.
32. Morrison AP, French P, Parker S, Roberts M, Stevens H, Bentall RP, Lewis SW (2007). Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophrenia Bulletin 33, 682-687.
33. Nelson B, Yuen HP, Wood SJ, Lin A, Spiliotacopoulos D, Bruxner A, Broussard C, Simmons M, Foley DL, Brewer WJ, Francey SM, Amminger GP, Thompson A, McGorry PD, Yung AR (2013). Long-term Follow-up of a Group at Ultra High Risk ('Prodromal') for Psychosis: The PACE 400 Study. JAMA Psychiatry 70, 793-802.
34. Nieman DH, Ruhrmann S, Dragt S, Soen F, van Tricht MJ, Koelman JHTM, Bour LJ, Velthorst E, Becker HE, Weiser M, Linszen DH, de Haan L (2014). Psychosis prediction: stratification of risk estimation with information-processing and premorbid functioning variables. Schizophrenia Bulletin 40, 1482-1490.
35. Power L, Polari AR, Yung AR, McGorry PD, Nelson B (2015). Distress in relation to attenuated psychotic symptoms in the ultra-high-risk population is not associated with increased risk of psychotic disorder. Early Intervention in Psychiatry. Published online: 15 March 2015. doi:10.1111/eip.12233.
36. Priebe S, Huxley P, Knight S, Evans S (1999). Application and results of the Manchester Short Assessment of Quality of Life (MANSA). International Journal of Social Psychiatry 45, 7-12.
37. Riecher-Rössler A, Pflueger MO, Aston J, Borgwardt SJ, Brewer WJ, Gschwandtner U, Stieglitz R-D (2009). Efficacy of using cognitive status in predicting psychosis: a 7-year follow-up. Biological Psychiatry 66, 1023-1030.
38. Rietdijk J, Dragt S, Klaassen R, Ising H, Nieman D, Wunderink L, Delespaul P, Cuijpers P, Linszen D, van der Gaag M (2010). A single blind randomized controlled trial of cognitive behavioural therapy in a help-seeking population with an At Risk Mental State for psychosis: the Dutch Early Detection and Intervention Evaluation (EDIE-NL) trial. Trials 11, 30.
39. Rijnders CAT, van den Berg JFM, Hodiamont PPG, Nienhuis FJ, Furer JW, Mulder J, Giel R (2000). Psychometric properties of the schedules for clinical assessment in neuropsychiatry (SCAN-2.1). Social Psychiatry and Psychiatric Epidemiology 35, 348-352.
40. Ruhrmann S, Schultze-Lutter F, Klosterkötter J (2010a). Probably at-risk, but certainly ill-advocating the introduction of a psychosis spectrum disorder in DSM-V. Schizophrenia Research 120, 23-37.
41. Ruhrmann S, Schultze-Lutter F, Salokangas RKR, Heinimaa M, Linszen D, Dingemans P, Birchwood M, Patterson P, Juckel G, Heinz A, Morrison A, Lewis S, von Reventlow HG, Klosterkötter J (2010b). Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Archives of General Psychiatry 67, 241-251.
42. Schultze-Lutter F (2009). Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept. Schizophrenia Bulletin 35, 5-8.
43. Schultze-Lutter F, Ruhrmann S, Picker H, von Reventlow HG, Brockhaus-Dumke A, Klosterkötter J (2007). Basic symptoms in early psychotic and depressive disorders. British Journal of Psychiatry. Supplement 51, s31-s37.
44. Simon AE, Umbricht D (2010). High remission rates from an initial ultra-high risk state for psychosis. Schizophrenia Research 116, 168-172.
45. Tropsha A, Gramatica P, Gombar V (2003). The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. QSAR & Combinatorial Science 22, 69-77.
46. Valmaggia LR, Stahl D, Yung AR, Nelson B, Fusar-Poli P, McGorry PD, McGuire PK (2013). Negative psychotic symptoms and impaired role functioning predict transition outcomes in the at-risk mental state: a latent class cluster analysis study. Psychological Medicine 43, 2311-2325.
47. van der Gaag M, Nieman D, van den Berg D (2013). CBT for Those at Risk of a First Episode Psychosis: Evidence-based psychotherapy for people with an 'At Risk Mental State'. Routledge Taylor & Francis Group: London and New York.
48. van der Gaag M, Nieman DH, Rietdijk J, Dragt S, Ising HK, Klaassen RMC, Koeter M, Cuijpers P, Wunderink L, Linszen DH (2012). Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial. Schizophrenia Bulletin 38, 1180-1188.
49. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L, Van Os J (2009). A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychological Medicine 39, 179-195.
50. Velthorst E, Nieman DH, Klaassen RMC, Becker HE, Dingemans PM, Linszen DH, De Haan L (2011). Three-year course of clinical symptomatology in young people at ultra high risk for transition to psychosis. Acta Psychiatrica Scandinavica 123, 36-42.
51. Velthorst E, Nieman DH, Linszen D, Becker H, de Haan L, Dingemans PM, Birchwood M, Patterson P, Salokangas RKR, Heinimaa M, Heinz A, Juckel G, von Reventlow HG, French P, Stevens H, Schultze-Lutter F, Klosterkötter J, Ruhrmann S (2010). Disability in people clinically at high risk of psychosis. British Journal of Psychiatry 197, 278-284.
52. Vittinghoff E, McCulloch CE (2007). Relaxing the rule of ten events per variable in logistic and Cox regression. American Journal of Epidemiology 165, 710-718.
53. Yung AR, Buckby Ja, Cosgrave EM, Killackey EJ, Baker K, Cotton SM, McGorry PD (2007). Association between psychotic experiences and depression in a clinical sample over 6 months. Schizophrenia Research 91, 246-253.
54. Yung AR, Nelson B, Stanford C, Simmons MB, Cosgrave EM, Killackey E, Phillips LJ, Bechdolf A, Buckby J, McGorry PD (2008). Validation of 'prodromal' criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophrenia Research 105, 10-17.
55. Yung AR, Nelson B, Thompson A, Wood SJ (2010). The psychosis threshold in Ultra High Risk (prodromal) research: is it valid? Schizophrenia Research 120, 1-6.
56. Yung AR, Phillips LJ, Yuen HP, Mcgorry PD, Pan H (2004). Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophrenia Research 67, 131-142.
57. Yung AR, Stanford C, Cosgrave E, Killackey E, Phillips L, Nelson B, McGorry PD (2006). Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophrenia Research 84, 57-66.
58. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby J (2005). Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Australian and New Zealand Journal of Psychiatry 39, 964-971.